![Jason Loveridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Loveridge
Directeur/Membre du Conseil chez
Corticrine Ltd.
Profil
Jason Loveridge is the founder of Parvulus Suisse SA, founded in 2011, serving as Chief Executive Officer from 2011 to 2014.
Dr. Loveridge was the founder of Invex Therapeutics Ltd., founded in 2019, serving as Non-Executive Chairman from 2019 to 2023.
Current jobs include Director at Corticrine Ltd., Managing Director at Warambi Ltd., and Director at Invex Therapeutics Ltd. (United Kingdom).
Former jobs include Chief Executive Officer at 4SC AG; Chief Executive Officer at Spark Therapeutics Ireland Ltd. from 2011 to 2016; Chief Executive Officer & Executive Director at Arthro Kinetics Ltd. from 2008 to 2009; Independent Non-Executive Director at Resonance Health Ltd. from 2013 to 2017; Director & Investment Manager at Korda & Co. from 1991 to 1995; Non-Executive Director at Biofrontera AG; Non-Executive Director at Actinogen Medical Ltd. from 2017 to 2018; Director at Anaconda Pharma SASU; Executive Director & Owner at Warambi SARL from 2005 to 2020; Director at JDS BioPharma Pty Ltd. from 2006 to 2020; Director at Parvulus Medical SAS from 2011 to 2014; Gérant Sénior at IT Asset Management SA from 2005 to 2007; Principal at BioPharma Capital Ltd. in 2003.
Education includes a doctorate from the University of Adelaide conferred in 1988 and an undergraduate degree from The University of New South Wales conferred in 1982.
Postes actifs de Jason Loveridge
| Sociétés | Poste | Début |
|---|---|---|
Corticrine Ltd.
 Corticrine Ltd. Pharmaceuticals: MajorHealth Technology Develops and Manufactures durgs | Directeur/Membre du Conseil | - |
Warambi Ltd. | Corporate Officer/Principal | - |
Invex Therapeutics Ltd. (United Kingdom) | Directeur/Membre du Conseil | - |
Anciens postes connus de Jason Loveridge
| Sociétés | Poste | Fin |
|---|---|---|
| INVEX THERAPEUTICS LTD | Fondateur | 10/07/2023 |
Warambi SARL | Directeur/Membre du Conseil | 01/01/2020 |
JDS BioPharma Pty Ltd. | Directeur/Membre du Conseil | 01/01/2020 |
| ACTINOGEN MEDICAL LIMITED | Président | 01/03/2017 |
| RESONANCE HEALTH LIMITED | Directeur/Membre du Conseil | 30/06/2017 |
Formation de Jason Loveridge
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Arthro Kinetics Ltd.
 Arthro Kinetics Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets biological implants | Health Technology |
IT Asset Management SA
 IT Asset Management SA Investment ManagersFinance ITAM is an active, growth-oriented investor and manages concentrated portfolios invested across regions and market caps in equity and equity funds from the information technology and biotechnology industries. The firm engages in bottom-up stockpicking and conducts in-house research independently from buy-side firms and brokerages. Their investment process begins with a sector-specific screening process to identify investment opportunities using proprietary quantitative models designed to determine the fair value of targeted stocks. They then conduct fundamental analysis with emphasis on factors such as management quality, technology differentiation, business model, financials as well as sales and marketing abilities. Finally they visit potential investees before making investment decisions. ITAM uses benchmarks such as the MSCI IT index as references, without however replicating them or even using them to build portfolios | Finance |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Resonance Health Ltd.
 Resonance Health Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare company, which involves in the development and commercialization of technologies & services for radiological images | Health Services |
BioPharma Capital Ltd. | Finance |
Korda & Co.
 Korda & Co. Investment ManagersFinance Acts as an alternative investment manager | Finance |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biofrontera AG
 Biofrontera AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops and distributes dermatological products | Health Technology |
Actinogen Medical Ltd.
 Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops new gene medicines to treat autosomal dominant genetic diseases | Health Technology |
Anaconda Pharma SASU
 Anaconda Pharma SASU BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Parvulus Suisse SA
 Parvulus Suisse SA Medical SpecialtiesHealth Technology Provides medical technology | Health Technology |
Warambi SARL | |
JDS BioPharma Pty Ltd. | |
Parvulus Medical SAS
 Parvulus Medical SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Corticrine Ltd.
Corticrine Ltd. Pharmaceuticals: MajorHealth Technology Develops and Manufactures durgs | Health Technology |
Invex Therapeutics Ltd.
 Invex Therapeutics Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company and develops therapeutics for neurological conditions | Health Technology |
Warambi Ltd. | |
Invex Therapeutics Ltd. (United Kingdom) |
